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Abstract
Chronic dyspnea is a potent, independent predictor of mortality and is prevalent in older
adults, yet assessment is inadequate and validated instruments are lacking. Underreporting and poor perception are common, and older adults develop self-restriction
strategies in order to improve breathing and quality of life. Chronic dyspnea-related
diagnoses result in 32% of inpatient admissions for community-dwelling elders in the
capstone study setting, but nurses do not use a validated dyspnea assessment instrument.
Professional organizations universally recommend multidimensional assessment of
dyspnea to improve early recognition of exacerbation. Emerging evidence indicates that a
brief patient-reported questionnaire format may be the most reliable way to measure
chronic dyspnea in the clinical setting. The DNP capstone explored the impact of using
the Dyspnoea-12 Questionnaire (D-12) on nurse self-efficacy related to dyspnea
assessment. Nurses were surveyed for six domains of self-efficacy before and after two
months of patient assessment with the D-12. In spite of the small sample size (n = 10),
improvement in nurse self-efficacy was demonstrated as a result of the intervention (χ2 =
7.054 [p = .008]; φ = 0.108, [p = .008]). Nurses recommended the D-12 in patients with
chronic dyspnea and at initial assessment, but not for universal use. Future research of the
mD-12 in larger patient cohorts in varied settings, and further study of assessment
efficacy in practicing nurses is recommended.
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Assessment of Chronic Dyspnea in Older Adults: Impact of the Dyspnoea-12
Questionnaire on Nurse Self-Efficacy
Background and Significance
Dyspnea is a symptom that nurses commonly encounter, affecting up to half of
patients in acute care, and one-quarter in ambulatory care settings (Charles, Ng, & Britt,
2005; Parshall et al., 2012). Chronic dyspnea is experienced by 25-46% of communitydwelling adults aged 70 or older (Ahmed, Steward, & O’Mahony, 2012; Ho et al., 2001;
van Mourik et al., 2014; Mullerova, Lu, Li, & Tabberer, 2014), and is a common
complaint for older adults presenting to emergency departments and inpatient settings
(Ahmed et al., 2012). Independent of age, gender, lung function, smoking, body mass
index, and comorbidities, chronic dyspnea is a potent predictor of mortality that is
associated with a 1.3 to 2.9 times greater risk of all-cause mortality at a 95% confidence
interval (Berraho et al., 2013; Pesola & Ahsan, 2014).
Dyspnea is the sensation of difficult or uncomfortable breathing (Mukerji, 1990).
Definitions of chronic dyspnea vary widely in clinical and research literature (Bausewein,
Farquar, Booth, Gysels, & Higginson, 2006). Mahler and colleagues (2010) defined
chronic dyspnea as difficult breathing that persists at rest, with minimal activity, or is
distressful despite optimal therapy of advanced lung or heart disease (p. 674), versus
Spector, Connolly, & Carlson (2007) who characterize chronic dyspnea as long-term,
persistent, and varying in intensity. The most commonly used definition of dyspnea is
that of the American Thoracic Society (ATS):
“A subjective experience of breathing discomfort that consists of qualitatively
distinct sensations that vary in intensity…The experience of dyspnea derives from
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interactions among multiple physiological, psychological, social, and
environmental factors, and may induce secondary physiological and behavioral
responses…but we emphasize strongly that dyspnea per se can only be perceived
by the person experiencing it. Perception entails conscious recognition and
interpretation of sensory stimuli and their meaning. Therefore, as is the case with
pain, adequate assessment of dyspnea depends on self-report” (Parshall et al.,
2012, p. 437).
Dyspnea in older adults is complex, multifactorial, progressive, and characterized
by repeated exacerbations. It is associated with chronic cardiorespiratory conditions such
as heart failure (HF) and chronic obstructive pulmonary disease (Mahler et al., 2010;
Parshall et al., 2012). Dyspnea is the most important disability-inducing factor in chronic
obstructive pulmonary disease (COPD), greater than stage of illness or comorbidity
(Braido et al., 2011). In a study comparing stable individuals with COPD and HF,
researchers found that 100% reported dyspnea, yet no significant difference in the
frequency of dyspnea, as measured by the number of times per month “severe to very
severe dyspnea”. However, day-to-day intensity of dyspnea was significantly higher in
subjects with COPD (de Souza Caroci & Lareau, 2004, p. 109). A review of nearly
500,000 Medicare patients demonstrated that dyspnea and pain commonly occur,
develop, and resolve together (Clark et al., 2014). “Breathlessness generates suffering
across the community for patients and their caregivers often for long periods” (Currow,
Higginson, & Johnson, 2013, p. 932).
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Ineffective Recognition and Treatment
Although thorough and accurate assessment is the universal cornerstone of
clinical care and treatment, numerous authors emphasize that deficient assessment of
chronic dyspnea is fundamentally associated with ineffective recognition, treatment,
management, and outcomes related to cardiorespiratory conditions in older adults.
Prompt recognition of the signs and symptoms of exacerbation in tandem with
appropriate medication management can help prevent hospitalization in HF (Schipper,
Coviello, & Chyun, 2012). Dyspnea is a predictor of hospitalization in COPD (Ong,
Earnest, & Lu, 2005).
The American College of Chest Physicians (ACCP) in their 2010 Consensus
Statement on the Management of Dyspnea stated, “…patients with advanced lung or
heart disease are not currently being treated consistently and effectively for relief of
dyspnea” (Mahler et al., 2010, p. 674). Improved assessment of chronic dyspnea is
critically needed to enhance earlier recognition, guide management and treatment, as well
as impact avoidable hospitalization and decrease unnecessary healthcare expenditures.
Older Adult Population and Dyspnea
For the purposes of this capstone, older adult is defined as an individual 65 years
of age or older. There are 44.3 million Americans in this age group, 14.1% of the total
population, more than at any other time in United States (U. S.) history (United States
Census Bureau [USCB], 2013). The USCB projects that the population aged 65 and older
will continue to grow dramatically until 2030, stabilizing at approximately 20% of the
total population. However, as “Baby Boomers” (people born between 1946 and 1964) age
to 85 and older, their numbers are expected to nearly quadruple from 5.5 million in 2010
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to 19 million by 2050 (Federal Interagency Forum on Aging-Related Statistics [FIFA],
2012, p. 22).

Year
1900
2000
2010
2030
2050

U. S. Older Population Change
Aged ≥ 65
% Total U. S.
Aged ≥ 85 years
years
population
3M
100 K
35 M
40 M
13%
5.5 M
72 M
20%
19 M

Figure 1 U. S. Older Population Change (FIFA, 2012)

Due to the growth in the aging population, the prevalence of older adults with
dyspnea will also rise. “Dyspnea, or breathlessness, is the most common symptom
reported by patients with COPD and CHF seeking medical help” (de Souza Caroci, &
Lareau, 2004, p. 102). Heart failure affects more than 5 million Americans; 12.7 million
have diagnosed COPD (American Lung Association, 2014). Increasing age is associated
with increasing prevalence in both diseases. COPD prevalence doubles each decade past
middle age (Centers for Disease Control and Prevention, 2015), while HF increases 10fold between from age 60 to 80 (Go et al., 2014). COPD prevalence is 19.2% in
Americans aged 70 or older (Buist et al., 2007), and projections indicate that COPD will
become the third leading cause of death by 2030 (World Health Organization, 2008).
Americans aged 80 or older have a 12.8-14.7% prevalence of HF (Azad & Lemay, 2014)
with total population numbers expected to grow in association with an overall aging
population.
Gaps in Care
The clinical setting where this Doctor of Nursing (DNP) capstone was conducted
is an outpatient department providing primary care in the place of residence to a cohort of
140-150 majority older adults with chronic disease. Cardiorespiratory-related conditions
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(CHF, COPD [including bronchitis], pneumonia, pulmonary fibrosis, respiratory failure
and shortness of breath [SOB]) account for 32% of acute care admissions for the patient
population—the most prevalent disease category. Hereafter, the capstone setting will be
referred to as Site.
Local nursing policies mandate the use of Lippincott’s Manual of Nursing
Procedures (Nettina, 2014) for dyspnea assessment, which requires physical assessment
and use of a single-item dyspnea assessment scale. Site nurses auscultate heart and lungs,
take vital signs, oximetry and consistently ask, “Are you short of breath?” Current
adherence only partially meets the standard of care; if the patient denies being short of
breath, no scale is utilized. However, Site practices are consistent with general practice in
that nursing dyspnea assessment usually does not include a validated tool (Baker et al.,
2013; Doran et al., 2014).
Home Care Practice
Effective nursing assessment of elderly adults with chronic dyspnea in the
community setting and related decision-making is a challenging dilemma, calling for
study and creative clinical practice improvements. A group of nurse researchers who
retrospectively investigated the application of clinical evidence to outcomes in home care
stated, “There are gaps in knowledge about the extent to which home care nurses’
practice is based on best evidence and whether evidence-based practice impacts patient
outcomes” (Doran et al., 2014, p. 274). Doran and colleagues (2014) noted that the home
is an unpredictable environment, healthcare visits are short and episodic, nurses have
more autonomy, and care is a shared approach with informal caregivers (p. 274). Of a
total of 978 reviewed charts, 909 patients were assessed for dyspnea on admission (93%),
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25.4% of which had dyspnea. Ninety-four percent had dyspnea present on both admission
and discharge: only 10% showed improvement during the course of care, and dyspnea
was unchanged or worse in 90%. Of the 20 evidence-based dyspnea interventions
studied, only 5 were documented in 90% of the appropriate cases. Significant dyspnea
score changes were associated with older age and a greater number of dyspnea
interventions. Dyspnea was assessed via a single nurse-defined measure (0 = absence of
symptoms to 3 = present at rest) of intensity (pp. 277-278). This study demonstrated that
while home care nurses assessed dyspnea 93% of the time at admission, they did not
elicit patient-reported indicators or physical factors such as oximetry with ambulation,
nor did they employ more than 5 of 20 evidence-based interventions in their care (p.
278). This large, very current study confirms the need for improvements in dyspnea
assessment quality and consistency in the home care setting.
Recliner Sleep Behavior
Dyspnea is recognizable in the home care environment where many elderly
people sleep in a recliner chair rather than a bed, often for many years. An exhaustive
literature review conducted between October and December 2014 failed to identify any
publications that addressed the prevalence or problem of recliner sleep behavior. This
author informally interviewed four experienced home care nurses and the Chiefs of
Pulmonary and Physical Medicine and Rehabilitation in the local organization. All agreed
that recliner sleep is a common phenomenon, but could likewise not identify any germane
clinical or epidemiological evidence. Notably, while they agreed that people often sleep
in recliners due to orthopnea or other respiratory-related issue, these experienced

NURSE SELF-EFFICACY AND CHRONIC DYSPNEA ASSESSMENT

8

clinicians were intrigued to have previously not considered recliner sleep behavior as a
potential indicator of dyspnea that could/should be included in regular assessment.
Theoretically, the foot-elevated semi-fowler’s position afforded by a recliner chair
is a self-care measure to relieve orthopnea, defined as an increase in dyspnea while
supine (Eltayara, Ghezzo, & Milic-Emili, 2001), or onset/worsening of dyspnea when
shifting from the sitting to the supine position (Duguet et al., 2000). Orthopnea is a
known risk indicator of poorly managed or progressive HF and COPD (Beck da Silva et
al., 2004; Boni et al., 2005; Duguet et al., 2000; Eltayara et al., 2001; Mukerji, 1990;
Torchio et al., 2006).
Self-Restriction Strategies
Patients with chronic dyspnea, especially the elderly, develop a significant
decrease in exercise tolerance that is directly proportionate to degree of airflow
limitation. In an attempt to prevent worsening dyspnea, patients self-restrict physical
activity, leading to a cycle of increasing exercise intolerance, progressive dyspnea,
exacerbations, hospitalizations, and mortality. As activity of self-restriction and lifestyle
adaptation becomes chronic, patients may underestimate the severity of their own
condition (van der Molen, Miravitlles, & Kocks, 2013, p. 463). Perhaps recliner-sleeping
behavior could be one such strategy that chronically dyspneic older adults use to control
or adapt to orthopnea. Considering the clear ACCP consensus statement (Mahler et al.,
2010) and perplexing observation of chronic recliner sleep behavior, healthcare
professionals may be missing an opportunity to recognize worsening respiratory status by
not consciously including queries about sleeping posture in nursing dyspnea assessments.
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Altered Symptom Reporting in the Elderly
Given that exacerbations of chronic cardiorespiratory conditions can be mitigated
or managed prior to escalation and need for hospitalization, early recognition of signs and
symptoms is critically important. However, in the elderly, self-perception and report of
symptoms is a challenge. While older adults experience more dyspnea, their accuracy at
detection and interpretation of early symptoms is worse than younger counterparts
(Jurgens, Hoke, Byrnes, & Riegel, 2009). For example, a study of 103 patients found that
those who scored five or more on a dyspnea visual intensity scale also answered “no” to
the question “Are you short of breath?” (MacDonald, Yates, Lance, Giganti, &
Chepurko, 2005, p. 260), indicating significant incongruity between younger and older
adults in accurately reporting dyspnea. Petersen, von Leupoldt, & Van den Bergh (2014)
found that self-report of dyspnea is more highly correlated with biopsychosocial factors
than actual physiological changes, concluding that dyspnea has subjective aspects similar
to pain that need to be considered when assessing (p. 94). These physiological and
psychological changes in aging are not fully understood, and studies are inconsistent
(Petersen et al., 2014).
Theoretical Framework: Self-Efficacy Theory
Care of the chronically dyspneic older adult is an on-going interaction between
patient and nurse to mutually identify the severity of symptoms and to provide
individualized care that is based on optimal assessment. Having discovered that
comprehensive assessment of chronic dyspnea is endorsed in the literature as generally
deficient in clinical healthcare, the decision was made to investigate nurse self-efficacy
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related to assessment of chronic dyspnea. Therefore, Bandura’s theory of self-efficacy
(1977) was chosen as the theoretical model for this capstone.
Self-efficacy (SE) is a concept first developed and described by Albert Bandura
(1977) to explain and predict behavioral change. “Perceived self-efficacy is defined as
people’s beliefs about their capabilities to produce designated levels of performance that
exercise influence over events that affect their lives. Self-efficacy beliefs determine how
people feel, think, motivate themselves and behave” (Bandura, 1994, p. 71). The author
hypothesized, “Expectations of personal efficacy determine whether coping behavior will
be initiated, how much effort will be expended, and how long it will be sustained in the
face of obstacles and aversive experiences” (Bandura, 1977, p. 191).
A foundational concept of SE is that while cognitive processes can and do
mediate behavioral change, mastery evolves best through effective performance. Four
principle sources of information lead to SE: performance accomplishments, vicarious
experience, verbal/social persuasion, and physiological states (Bandura, 1977, p. 191).
Performance accomplishment is essentially practice that leads to the accumulation of
experience and skills (Shortridge-Baggett, 2002), and is the most influential of the four
information sources (Bandura, 1977). Vicarious experience is observation of desired
behavior in similar others, and can influence the observer to believe that successful
capability and mastery are possible for her/him. Verbal/social persuasion is the receipt of
positive encouragement and/or reinforcement of expected behaviors from respected
mentors or co-workers. Self-appraisal is the judgment of one’s own capabilities through
internal cues. Feedback is received through personal physiological and psychological
responses (Shortridge-Baggett, 2002). The four information sources would suggest that
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through the introduction and use of a clinical assessment tool, nurses in the chosen
capstone practice site would have the opportunity to increase self-efficacy. Hence,
Bandura’s SE Theory underpins the design of this capstone (see Appendix A).
Self-efficacy is often operationalized in SE scales as a subject’s “confidence” in
his/her ability to perform specific tasks or impact behaviors. “Confidence” is considered
to be an appropriate modifier for questionnaires (Sheer, 2014, p. 88). Therefore, the use
of the term “confidence in” is used in the pre and post-test questions related to nurse selfefficacy in this capstone. However, it is important to understand that self-efficacy and
self-confidence are not synonymous (Lorenz, Gregory, & Davis, 2000, p. 183).
Literature Review
The evidence of impaired symptom recognition/reporting and altered sleeping
posture in elders with chronic dyspnea, limited application of evidence based practice by
home care nurses, and the high general and local site prevalence of chronic dyspnea
clearly warrant improvements in nursing practice related to dyspnea assessment. A
review of the literature to determine the most effective strategies to address or impact
nursing practice related to self-efficacy of dyspnea assessment, as well as the most
appropriate clinical dyspnea assessment tool was conducted.
Description of Search Strategies
Numerous keywords were used to search the literature: dyspnea, dyspnoea,
breathlessness, assessment, instrument, tool, scale, questionnaire, nurse, recliner sleep,
chair, reclining sleep, and sleep posture. The search was limited to English language
publications and human subjects. PubMed, CINAHL, and Google Scholar were the main
databases utilized. All retrieved materials were extensively hand-searched. Where an
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author was noted to have published several pieces of relevant literature, a SCOPUS
search was conducted.
Clinical Practice Guidelines
One evidence-based nursing plan of care for the assessment, planning,
intervention, and evaluation for dyspnea was discovered (Spector et al., 2007). The plan
includes ten elements, including that dyspnea should be assessed from the patient’s
perspective whenever possible via an assessment instrument (Level V evidence). Dyspnea
assessment should include: quality and timing of dyspnea; alleviating and precipitating
factors; associated symptoms; physical assessment and pulmonary function measures as
indicated; pulmonary factors such as hypoxia or increased work of breathing; and nonpulmonary factors such as pain, anxiety, depression, and fluid overload (p. 53).
No clinical practice guideline (CPG) specific for dyspnea currently exists in the
National Guideline Clearinghouse, but a comparable guideline and supplement for COPD
was discovered. The CPG recommendations are:
Recommendation 1.0 - Nurses will acknowledge and accept the patients' self-report of
dyspnea (Level of Evidence = IV).
Recommendation 1.1 (updated 2010) - All individuals should be assessed; assessment
should include: 1) Level of dyspnea - If able to self-report, measure using a quantitative
scale such as a visual analogue or numeric rating scale. If unable to self-report, present
level of dyspnea should be measured using a quantitative scale such as the Respiratory
Distress Observation Scale (RDOS); 2) Usual level of dyspnea – Use a quantitative scale
such as the Medical Research Council Dyspnea Scale; 3) Vital signs, pulse oximetry,
chest auscultation, chest shape, movement, and abnormalities, peripheral edema,
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accessory muscle use; 4) Presence of cough/sputum; 5) Ability to complete a full
sentence; 6) Level of consciousness; and 7) Swallowing difficulties (Level of Evidence =
IV; Registered Nurses' Association of Ontario [RNAO], 2010).
Nurse Self-Efficacy
An exhaustive literature review revealed voluminous information focused on
nursing student and patient-focused populations related to self-efficacy. However, only
six relevant studies were identified related to SE in practicing nurses (Fry, MacGregor,
Hyland, Payne, & Chenoweth, 2015; Fry & MacGregor, 2014; Johnson, Hong, Groth, &
Parker, 2010; Manojlovich, 2005; Welsh, 2014; Winslow, DeGuzman, Kulbok, &
Jackson, 2014). The literature demonstrated that SE is a positive mediator in professional
practice behaviors (Manojlovich, 2005), competency (Welsh, 2014), and clinical
decision-making (Fry & MacGregor, 2014). Self-efficacy is a critical attribute in quality,
compassionate clinical care, and important for the acquisition of skill and knowledge (Fry
et al., 2015). There is a demonstrated association between learning and development in
practicing nurses and work attitudes and performance (Johnson et al., 2010).
Additionally, nurses who pursue academic advancement beyond initial preparation have
higher SE, but not at the level of statistical significance (Winslow et al., 2014).
Manojlovich (2005) theorized that SE would positively impact nursing practice
behaviors by interacting with nursing leadership and structural empowerment to move
practice toward more professional and less task focused behavior. The author surveyed
500 Michigan nurses, with a 73% return rate, finding that structural empowerment
contributed to professional practice behaviors indirectly through self-efficacy. The author
concluded that if partially mediated through SE, professional nursing practice might
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improve when the environment offers nurses opportunities and power through resources,
support, and information (p. 271). Johnson and colleagues (2010) conducted a
correlational survey of 404 nurses “at all grades and teams” (p. 612), and demonstrated
that nurses with role-breadth self-efficacy (the perceived capacity to perform a broad
range of roles) were more likely to have higher clinical performance and work attitudes
(p. 609).
In a multicenter study of 52 participant emergency room nurses, Fry &
MacGregor (2014) found SE to be an important factor in clinical decision-making,
recommending educational strategies to support self-confidence (tested as self-efficacy)
and resilience (p. 91). Further, Fry and coworkers (2015) followed-up with a study of 80
emergency department nurses in multiple centers, demonstrating that SE was gained
through “nursing praxis”, defined as the sum of nursing experiences (p. 1623). The
authors concluded that nursing experience, self-efficacy, confidence, and personal
relationships were reflexive in that they were acquired as a result of practice and are
important enablers of appropriate, timely and compassionate care (p. 1628).
Welsh (2014) concluded that although nurse self-efficacy is an important
characteristic of general nursing competency, literature is currently limited. With the aim
of a developing a greater understanding of practice ability and skill enhancement, the
author developed and tested a 16-item Nursing Care Self-Efficacy Scale (NCSES) that
demonstrated early validity and reliability. Germane to the question of nurse self-efficacy
related to assessment of chronic dyspnea assessment explored in this capstone, Welsh
notes that her NCSES instrument is meant to measure SE with respect to the five
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fundamental components of the nursing process (assessment, diagnosis, planning,
implementation, and evaluation), the first of which is assessment (Welsh, 2014, p. 374).
Inadequate Dyspnea Assessment
Numerous authors concluded that the assessment of dyspnea is inadequate and
use of validated measures of dyspnea are lacking (Jones, Price, & van der Molen, 2011;
Mahler et al., 2010; Parshall et al., 2012; Yorke & Savin, 2010; Yorke, Moosavi,
Shuldham, & Jones, 2010). Researchers agreed that conventional measures of respiratory
function such as spirometry and peak flow in COPD and brain natriuretic peptide and
arterial blood gasses in HF do not correlate well with dyspnea and the associated impact
on quality of life (Crisafulli & Clini, 2010; Parshall et al., 2012; van der Molen et al.,
2013). Improved management requires a combination of assessments that include
physical function, exacerbation history, and impact on overall functional status. Socrates
& Mebazaa (2009) endorsed that tools can be utilized to measure dyspnea regardless of
the underlying etiology (p. 639). Numerous authors concluded that there is not enough
current evidence to recommend any specific measurement tool (Bausewein et al., 2006;
Jones, Miravitlles, van der Molen, & Kulich, 2012; Mularski et al., 2010; Weldam,
Schuurmans, Liu, & Lammers, 2013); neither the ATS nor ACCP Consensus Statements
recommended a particular instrument (Mahler et al., 2010; Parshall et al., 2012).
There is emerging evidence that a short patient-reported questionnaire format may
be the most reliable way to measure chronic dyspnea in the clinical setting (Jones et al.,
2011; Jones et al., 2012; Mahler et al., 2010; Yorke & Savin, 2010). To fully characterize
disease burden, patient-reported outcomes should be followed independent to physical
outcomes (Oga et al., 2007). A structured review of respiratory questionnaires concluded:
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“Patient-reported outcome measures (PROMs) offer enormous potential to improve the
quality and results of health services. They provide validated evidence of health from the
point of view of the user or patient” (Davies, Gibbons, & Fitzpatrick, 2009, p. 3).
Dyspnea Assessment Instruments
Historically, dyspnea has been assessed either directly through single item scales
in patients at rest or during varying types of exercise or levels of exertion, and indirectly
through queries of activities that are impaired due to breathlessness or impact of
symptoms on quality of life. Direct measures do not capture the complexity of dyspnea,
and indirect measures do not measure intensity of dyspnea itself, but rather are measuring
the impact of dyspnea on physical activity, function, or quality of life (Yorke et al., 2010,
p. 21). Also, the majority of tools were developed and validated only for use in COPD or
for use in research rather than clinical practice (Bausewein et al., 2006; Jones et al., 2012;
Yorke & Savin, 2010).
One systematic review (SR) of measurement instruments for breathlessness in
clinical care was discovered. Bausewein and colleagues (2006) identified 33 dyspnea
assessment instruments meeting inclusion criteria. A summary of their comprehensive
findings is as follows:
•

No one tool is comprehensive enough. Combining a unidimensional (e. g. Visual
Analog Scale) tool and disease-specific or multidimensional tool (Chronic
Respiratory Disease Questionnaire) is recommended (pp. 399-400).

•

A lack of universal definition of breathlessness or dyspnoea (sic) hinders analysis
and comparison of instruments (p. 406).
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Most instruments were developed for COPD, with some tested in healthy
individuals. Validated tools include 6/11 in respiratory disease, 1/11 in HF, and
3/11 in cancer (p. 403)

•

Six are self-administered, three are interviewer or computer completed, and two
are mixed (p. 403).

•

Of the 33 instruments reviewed, the following were measured: severity (25),
frequency (10), distress (7), intensity (4), associated symptoms (17), functional
status questions (28), psychological dimensions (15), social dimensions (13),
spiritual dimensions (0), and palliative care in malignant disease (4; p. 406).
Refer to Appendix B for a more complete summary of the specific instruments.

(Note that the Dyspnoea-12 instrument was published after this 2006 SR was published.
Jones and colleagues (2012) acclaim the Dyspnoea-12 as “a novel approach” with
importance “yet to be established” [p. 701]).
Dyspnoea-12 Questionnaire
The Dyspnoea-12 Questionnaire (Yorke et al., 2010) was chosen for this capstone
because it has been validated in multiple diagnoses, is patient self-reported, is short and
quick enough to be appropriate for clinical use, is not limited to measuring dyspnea
against an index activity, and demonstrates adequate sensitivity to appreciate changes in
intensity and severity (Yorke et al., 2010). The Dyspnoea-12 Questionnaire (D-12) is a
12-item measure of the severity of dyspnea in physical and affective domains. Each
question is assigned a patient-reported value on a 0-3 scale of “check this none” = 0,
“mild” = 1, “moderate” = 2, or “severe” = 3 for a possible score of 0 (least dyspnea) to 36
(most dyspnea).
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Yorke and colleagues (2010), a team of two PhD nurses, an exercise physiologist,
and a pulmonologist physician developed the D-12. Through an extensive English
language literature review, the researchers identified 81 descriptors of dyspnea and
breathlessness. These 81 descriptors were then validated in patients with COPD, HF and
interstitial lung disease, statistically analyzed, and distilled down to 12 descriptor phrases
in two categories: physical and affective. The tool has since been validated in asthma and
pulmonary hypertension, and is currently being translated into other languages (Yorke, &
Savin, 2010; Yorke et al., 2010; Yorke & Armstrong, 2014).
Project Purpose
The purpose of this DNP capstone was to investigate whether the use of a patient
self-reported dyspnea assessment questionnaire would improve nurse self-efficacy related
to dyspnea assessment. The project surveyed the self-efficacy and satisfaction of Site
nurses related to dyspnea assessment before and after a two-month period of using the
validated Dyspnoea-12 Questionnaire (Yorke et al., 2010) during patient visits. For
purposes of the capstone, the complete unaltered Dyspnea-12 Questionnaire served as the
first section of the assessment tool. For the capstone study instrument, a second section
was added to assess for recliner sleeping behavior. This final 2-part assessment tool will
be referred to as the “Dyspnea-12 with modifications” (mD-12), and this language is used
throughout the remainder of the paper. The mD-12 (see Appendix C) was formatted for
use as a clinical template, and was envisioned as being embedded into the electronic
medical record (EHR) to promote nurse efficiency, ease of use, and documentation.
Based on the one-group pre/post-test design of the capstone, the survey
instruments were developed based on extensive literature review of Bandura’s published
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materials on self-efficacy (Bandura, 1977; Bandura, 2006; Sheer, 2014) and the primary
investigator’s experience with chronically dyspneic patients. The pre-test and post-test
instruments can be found in Appendices D and E respectively. Other topics investigated
were: nurse opinion of the template and process, rate of template utilization, and inpatient
admission rate for cardiorespiratory related conditions during the period of clinical
template use.
Capstone Goals and Objectives
1. To improve nurse self-efficacy related to assessment of chronic dyspnea in older
adults.
a. At least 90% of the nurse study group will demonstrate improved selfefficacy scores on the post-test survey immediately following the data
collection phase (13 March 2015).
b. At least 85% of the nurse study group will demonstrate satisfaction with the
clinical template based on qualitative responses to the post-test survey (16
March 2015).
2. To improve management of chronic dyspnea in community-dwelling older adults.
a. By the end of the data collection phase (13 March 2015), at least 90% of
patient visits will have dyspnea assessed utilizing the dyspnea clinical
template.
b. During the two-month data collection phase while the clinical template is in
use, total inpatient admissions for cardiorespiratory related conditions will
drop at least 5% from baseline (32% of total admissions) for Site patients.
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Design and Methods
Ethics and Protection of Human Subjects
The University of North Dakota (UND) Internal Review Board granted ethics
approval for the capstone as an exempt research study. The primary investigator’s Site
organization Nursing Evidence Based Practice (EBP) Work Group granted approval as an
EBP project exempt from Internal Review Board (IRB) procedures. No consent forms
were required by either body, as completion of pre-test and post-test forms served as
implied consent. No compensation was provided. Confidentiality and privacy were
assured to subjects at outset, and maintained through storage on internally encrypted
computer spreadsheets or locked in the main investigator’s office. Due to UND IRB
requirements, data will be maintained for three years and then destroyed in compliance
with stringent internal Site policies. Further, in order to safeguard the anonymity of a very
small study group, no demographic data was gathered. The elderly adults whom the
nurses assessed during the capstone were a potentially vulnerable population, but
enjoy(ed) rigorous site-specific safeguards and oversight during the study period through
three years of required storage.
Setting and Organization
This DNP capstone was conducted within an outpatient department where
primary care is delivered in the place of residence to a cohort of 140-150 majority older
adults with chronic illness. The full interdisciplinary team of 25 included a nurse program
director, two part time physicians, three certified nurse practitioners, nine registered
nurses, two clinical pharmacists, two social workers, and one each: psychologist, physical
therapist, occupational therapist, physical therapy assistant, and registered dietician.
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The setting was an outpatient department of a governmental healthcare
organization that resides in a Western United States city of 300,000 and provides
healthcare services to 94,000 individuals on an annual budget of $160 million. A staff of
980 supports an on-site outpatient department, a 46-bed secondary care hospital, an 11bed in-patient substance abuse ward, and a 28-bed skilled nursing facility (SNF) with 8bed hospice unit, and three community outpatient clinics at a distance from the main
campus. The organization delivers 10,995 acute care visits, 6,659 SNF bed days of care,
and 213,565 ambulatory care visits annually. The umbrella organization of the local Site
employs a total of 243 RNs.
Population Description
The study population was registered nurses and nurse practitioners employed
within an outpatient department providing primary care in the place of residence to a
cohort of 140-150 majority older adults with chronic disease. For the purposes of this
project, nurse was defined as a registered nurse (RN) or Nurse Practitioner (NP)
employed at the Site, including nine RNs and two NPs (in addition to the primary
investigator). Because the Site had a small staff, a decision was made to include all nurses
irrespective of level of education or practice in order to boost the capstone sample size. In
the Site, 77.7% (7 of 9) RNs hold bachelor’s degrees and 22% (2 of 9) hold master’s
degrees. In terms of gender, two (22%) of the Site nurses are male. All Site RNs are
Caucasian and aged 46 years or younger.
Design
The capstone design was a one group pre and post-test design (Issel & Handler,
2013) to measure nurse self-efficacy related to assessment of chronic dyspnea. The study

NURSE SELF-EFFICACY AND CHRONIC DYSPNEA ASSESSMENT

22

population was drawn from a purposive convenience sample of available RN and NP
staff at the Site who were analyzed as a group through anonymous unmatched pre-test
and post-test surveys in order to meet expedited UND and Site IRB constraints. This
design was chosen for its straightforward applicability to evidence based practice, and
accessibility to a targeted nurse/older adult population. The design included quantitative
analysis to investigate nurse satisfaction with the template, ideas for revision, and clinical
practice improvements that may result from participation in the study. All Site RNs (9)
and NPs (2) were invited to participate voluntarily. Data collection was conducted for
nine weeks.
Subjects were asked to use the Dyspnea-12 Questionnaire with additional
questions to assess for sleeping posture during all patient visits and document each
assessment in the electronic health record (EHR) template. The complete unaltered D-12
Questionnaire served as the first section of the capstone assessment tool. A second
section was added to assess for recliner sleeping behavior. The final 2-part assessment is
referred to as the D-12 with modifications, or mD-12. While the terminology
“modifications” and “modified” is utilized here, it is important understand that the
validated D-12 instrument itself was not modified in any way. The two-part mD-12 was
formatted for use as a clinical template, and was envisioned as being embedded into the
EHR for efficiency and ease of use by the nurses (see Appendix C).
Anticipated results of the capstone included improved nurse self-efficacy related
to dyspnea assessment, as well as quantitative and qualitative nurse satisfaction with the
mD-12 instrument, and improved assessment of chronic dyspnea in community-dwelling
older adults. Secondary outcomes that were considered, but were beyond the scope of the
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capstone intervention were: potentially fewer emergency department episodes and
inpatient admissions for respiratory exacerbations and associated reduction in healthcare
costs, improved nursing articulation, documentation, and clinical decision-making related
to chronic dyspnea, and improved management of patients with chronic dyspnea.
Data Analysis and Interpretation
Sampling and Data Collection
The project was initiated on January 12, 2015 with a classroom-based session for
nurses in the department, a total of nine registered nurses and two certified nurse
practitioners (see capstone timeline Appendix F). The main investigator conducted the
session. The agenda included an explanation of the study, rights to accept or decline
participation, and assurance of participant understanding prior to beginning the study.
The pre-test was administered, the nurses were given a copy of the assessment template,
its use was explained, and questions answered. Template use during patient visits began
the day of the session and pre-test. Nurse and NP subjects were asked to assess dyspnea
with the template at each nursing visit during the subsequent two months. Because the
standard method of documentation for Site staff is to take hand-written notes while in the
home, and transfer them into the computerized medical record following the visit, the
subjects used a paper copy of the template during assessment of the patients, and then
transferred the information into the EHR. In compliance with UND and Site IRBs, paper
copies were given to the main investigator anonymously; the copies were counted and
destroyed. After nine weeks of template use, the post-test was administered on March 16,
2015, followed by a discussion of nurse subjects’ opinion of the template and
implications for practice.
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Analysis
The Site Program Director provided the main investigator with a report of the
total number of patient visits, rate of associated template usage, and in-patient admission
count with diagnosis. The template completion and visit reports were provided as a list of
RN or NP subjects. Therefore, it was possible to perform separate analyses of the RN and
NP groups. The results of the pre-test and post-test self-efficacy Likert-type questions (1
through 6) were each examined for trend identification and statistical analysis; remaining
qualitative queries were compiled and analyzed.
Template Use and Completion
Nine RNs and one NP completed the study. Nine RNs and 2NPs took the pretest.
The second NP had zero template utilization, opted out of the post-test, and was therefore
excluded from the data analysis as a non-participant. During the nine-week data
collection period, the participating RN/NP group conducted a total of 368 visits, ranging
from an individual subject low completion of 1 visit to an individual subject high
completion of 59 visits. The template completion mean was 43.91%, standard deviation
31.58%, and range was 0.0% to 90.2% of the visits for the ten participating subjects.
Lower visit utilization was directly correlated with markedly lower template
completion in three subjects (see Appendix G, Tables G1 and G2). There was no
significant change in acute care admission rate related to cardiorespiratory diagnoses
(33.3% versus 30.1% respectively) for the study period compared with calendar year
2014 (see Appendix G, Table G3). In spite of the small sample size (n = 10), the ShapiroWilk test confirmed that the data are normally distributed (p > .05; see Appendix H for
statistical analyses)
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Self-Efficacy Pre-Test/Post-Test Comparison
The purpose of the first six questions on the pre-test and post-test (SE-6) was to
measure the change in nurse self-efficacy with respect to: assessing dyspnea in general, in
familiar and unfamiliar patients, making sound clinical decisions about, accurately
documenting, and articulating changes related to dyspnea. For consistency, the SE-6
questions on the pre-test were exactly duplicated on the post-test. Each was a 5-point
Likert-style question, where nurses’ choice of responses ranged from “Strongly Agree”
(quantitatively, “5”) to “Strongly Disagree” (quantitatively, “1”). The distribution of
responses is displayed in Appendix G, Table G4.
Participant responses for the SE-6 were dichotomized into either “Strongly
Agree” (SA) or “not Strongly Agree” (n-SA) with an a priori prediction that the number
of post-test “Strongly Agree” responses out of all 300 possible responses for that test
would be greater than all 300 possible responses of the pre-test. A chi-Square Test-ofIndependence analysis was performed to determine association between SA (higher
efficacy) and n-SA (lower efficacy) before and after the period of patient assessment with
the mD-12 template (intervention). All expected cell frequencies were greater than five.
There was a statistically significant association between an increase in self-efficacy
related to dyspnea assessment as measured by SA responses and n-SA by nurses before
and after using the mD-12 instrument for patient assessment, χ2 (1) = 7.054 (p = .008; See
Appendix H; Tables H1 through H12). There was a small association (effect size)
between improved self-efficacy and template use, φ = 0.108, (p = .008). That is, nurses
were 7.4 times more likely to respond “Strongly Agree” after the intervention than
before.
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Qualitative Data
The capstone pre-test questions 7 through 10 and post-test questions 13 through
19 gathered qualitative responses related to dyspnea assessment and template use. No
formalized method was applied for analysis. Subject responses are listed verbatim for the
pre and post-tests in Appendices I and J, respectively, and summarized as follows:
•

Use the mD-12 with associated diagnoses, in patients with existing chronic dyspnea,
or with initial or quarterly assessments. It is not appropriate for universal use.

•

Shorten or simplify the tool; revise the scale to account for at rest versus with
activity; revise “none, mild, moderate, or severe” to “never, rarely, sometimes, or
frequently”.

•

The Questionnaire is helpful to encourage patient discussion, better identify degree of
dyspnea and emphasize the importance of assessing for sleeping posture.

•

Nurses generally valued having a more thorough set of queries to intensify patient
assessment and reported that chronically dyspneic patients also appreciated the
approach and questionnaire. Some patients not dyspneic were frustrated/impatient
with the assessment.

•

Nurses who would choose to use the tool in the future were mixed:
o No (n = 3) – “can assess without it, too difficult for the patient or want to qualify
answers/tell stories, did not learn anything new.”
o Yes (n =4) – “helpful in ‘pulling’ answers from patients; one subject wrote, “Yes:
I learned more about dyspnea in my patients. I didn’t know how short of breath
some of them really are.”
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o Yes, with changes (n = 3) – “only with patients who actually have dyspnea…
would modify, and use for initial assessment and change in condition.”
•

Nurses cited a majority of the dyspnea assessment elements that are included in the
Clinical Practice Guideline (RNAO, 2010), implying that they were well-educated
and well-informed clinicians prior to the pre-test and information session.

Summary Discussion and Interpretation
Nine RNs and one NP completed the study, with a total RN mD-12 template
usage of 59.06% (189/320 visits); NP usage was low at 16.67% (8/48) of participating
NP visits during the study period. Overall total RN/NP mD-12 template usage was
53.53% (197/368 visits). There was no demonstrated change in acute admission for
cardiorespiratory diagnoses during the study period, compared with the previous year. In
spite of its limitations of small sample size and low powered design, this capstone has
demonstrated improved nurse self-efficacy related to mD-12 template use as measured by
an increase in “Strongly Agree” in the six questions related to assessment of chronic
dyspnea, and a statistically significant change in chi-square test-of-independence (p =
.008; effect size φ = 0.108) for the study group. Nurse satisfaction with the mD-12 and
embedded template appeared to correlate in both positive and negative directions with
targeted patient status. That is, nurses deemed the mD-12 satisfactory if the patient being
assessed had chronic dyspnea or a known cardiorespiratory diagnosis, and less
helpful/useful when used indiscriminately or universally to assess all patients.
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Strengths and Limitations
Threats to Internal Validity
Notable threats to internal validity in this capstone were attrition, maturation,
diffusion (Kirchhoff, 2009, pp. 122-127), and testing (Pollit & Beck, 2012, p. 246).
•

Attrition: There was substantial attrition during the study period. Participation of the
two NPs was negligible. NP “A” made 42 visits during the study period, did not
assess with the template at any of the visits or take the post-test, and was therefore
excluded from the total participation count. NP “B” completed pre and post-tests,
completed 8/48 visits, but was retained in the total sample. The total study visit
number prior to exclusion of NP “A” was 410, and after exclusion was 368.
Therefore, NP template completion was 8/368 or 2.17% (versus 8/410 [1.95%]
counting all visits during the data collection period).

•

Maturation: As the data collection period progressed, some subjects’ template
completion became inconsistent. Post-study, subjects commented that there was
greater willingness to use the mD-12 with patients who had dyspnea, but considered
its use with every patient inappropriate. While this element led to lower visit
assessment completion, it may also be an empirical indicator of growing self-efficacy:
Were nurses making an independent clinical judgment of whether or not to assess
with the mD-12 based on patient diagnosis, status, and experience with the tool?

•

Diffusion – Interaction among subjects was noted to occur informally throughout the
data collection period, and may have affected responses. In spite of requesting that
the nurses not discuss the study with each other until completion of the data collection
period, the small staff size, nature of office setting, and interpersonal interactions
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rendered this request unreasonable. However, given the capstone design, diffusion
may have served serendipitously as a “vicarious experience” among nurse subjects to
positively influence self-efficacy.
•

Testing – Subject familiarity with a testing instrument or questions can enhance
performance. “It has been found, particularly in studies dealing with attitudes, that the
mere act of collecting data from people changes them” (Pollit & Beck, 2012 p. 246).
In this study, simply attending the information session and taking the pre-test could
have impacted nurse responses on the post-test.

Template Not Embedded
The less than anticipated template completion rate (original goal of 90% versus
actual of 53.5%) is likely directly related to reversal of an important design element.
Initial approval had been given to embed the template within the nursing note, but was
reversed prior to starting data collection. Therefore, to document the assessment in the
EHR, subjects were required to take several extra steps to open and load the template. A
majority of the nurses endorsed this as a significant barrier related to low completion
numbers because they either forgot or did not have enough time to complete the
documentation. Several subjects verbalized that had the tool been embedded within the
nursing note, they would have been cued to conduct the assessment more consistently.
The mixed survey response about ease of use of the template/assessment may
have also been directly related to the data collection design. Had it been possible to
document the assessment directly into the EHR at the time of patient visit, completion
numbers and nurse satisfaction may have shown more positive results. Other negatives
associated with low completion numbers were that nurses found the assessment
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inappropriate for patients who did not have chronic dyspnea, patients attempted to
quantify their answers based on during activity versus at rest, and subjects found the tool
too long during a busy clinical day.
Limited Time Period
This capstone was limited by a short time period. Data collection took place from
January through March 2015. A longer time period would allow a repeated (matched
measures) design or direct patient study group design. This capstone project demonstrates
the preliminary study of an important practice problem of notable clinical significance
with great potential for further study.
Cognitive Impairment
Patient self-reported assessment instruments such as the D-12 and mD-12 have
limited usefulness in patients with moderate to severe cognitive impairment. This is an
important limitation of the capstone because the prevalence of cognitive impairment is
approximately 6-10% at age 65 and increases with age (Chapman, Williams, Strine,
Anda, & Moore, 2006). Therefore, alternative means of assessing breathlessness in
cognitively impaired older adults will require future consideration and research.
Implications and Future Directions
The capstone has demonstrated two key findings. First, nurse self-efficacy related
to chronic dyspnea assessment improved after two months’ use of a validated patient selfreported questionnaire, the modified D-12. After using the mD-12, nurses in this study
group were significantly more confident in assessing, documenting, articulating, and
making clinical decisions about chronically dyspneic patients. Nurses verbalized partial
satisfaction with the mD-12, recommending best application for initial assessments, to
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assess for dyspnea-related recliner sleep behavior, and in patients with cardiorespiratory
related diagnoses, but not universally. These findings are preliminary, and will require
replication in larger cohorts and varied clinical settings, but are a pilot demonstration of
clinical effectiveness. As such, the capstone reflects the preliminary study of an
important practice problem of notable clinical significance with great potential for further
study.
The mD-12 remains available as a clinical template within the Site EHR that RN
or NP staff can access and use at any time. There is on-going discussion about the
possibility of adding the questionnaire or a streamlined version to required initial and
quarterly patient assessments, and for use as a telephone triage tool. Site staff has also
recommended that caregivers be educated to use the mD-12 questions with patients.
Particular future research is recommended with the mD-12 in telephone triage of
chronically dyspneic patients. The quantifiable elements within the mD-12 related to the
physical and affective domains of dyspnea could be beneficial to clinical staff attempting
to make a decision about the urgency of changes in patient condition. An acute escalation
in the mD-12 score could help guide medication management, need for emergent versus
non-emergent services, and patient education. Given that older adults often under-report
or misinterpret changes, the mD-12 also has the potential for use in patient selfmanagement, as chronically dyspneic adults (if cognitively intact) could be taught to selfadminister the tool. This is also a potential opportunity for future study that could
ultimately lead to clinical usefulness.
Future study using the mD-12 as a research tool to measure direct patient
outcomes in larger cohorts of older adults in other healthcare settings, in patients with
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specific related diagnoses, and in younger adults is recommended. Specifically, study of
older adults with the mD-12 is recommended in outpatient, acute care, emergency
department, cardiac and pulmonary rehabilitation, skilled nursing facility, and in
palliative care and hospice. Given the dearth of existing literature, future research of
recliner sleep behavior using the mD-12 is highly recommended. Further study of
assessment self-efficacy in practicing nurses is also recommended. Future research could
include a nurse or NP study group with repeated (matched) measures, or a direct patient
study group.
Potential Cost Efficiency
If used purposefully to assess patients with cardiorespiratory conditions or
symptoms, the mD-12 could potentially improve clinical care and cost efficiency in
varied settings of care with elderly adults including reduced ambulatory care and nurse
home visits. Improved recognition of worsening dyspnea, leading to quicker treatment of
less serious exacerbations, fewer emergency episodes, fewer preventable acute care
admissions and readmissions, and improved management over time could each
potentially lead to significant cost avoidance. Again, the brevity and numerical scale of
the tool could be easily and inexpensively adapted for use in nurse telephone triage to
quantitate patient changes, and enhance the articulation, clinical decision-making, and
documentation of dyspnea.
Conclusion
Bausewein, Booth, & Higginson (2008) state the following about dyspnea in
advanced disease: “Regular, standardized assessment of the severity of this distressing
symptom is not yet considered mandatory in clinical practice, yet without this there can
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be no accurate assessment of the effectiveness of interventions and necessary changes of
treatment” (p. 95). Nursing assessment of chronic dyspnea in the older adult population is
clearly an important issue that calls for creative strategies and clinical improvement. An
introductory session and associated use of a clinical template based on patient selfreported outcome measures was aimed at increasing nurse self-efficacy and concomitant
improved practice quality. The overall purpose of this capstone was to increase dyspnea
assessment-related self-efficacy in nurses caring for older adults with chronic dyspnea, to
identify a tool acceptable to nurses for assessing dyspnea in clinical practice, and to
improve assessment of chronic dyspnea in community-dwelling older adults.
In summary, the capstone addressed the problem of inadequate dyspnea
assessment of older adults in the home care setting. The literature confirms that chronic
dyspnea is a potent, independent predictor of mortality and is prevalent in older adults,
yet the assessment of dyspnea is insufficient and use of validated measures is inadequate.
Older adults either under-report or have poor perception of chronic dyspnea, developing
strategies (such as sleep in upright postures) that self-restrict daily activities in order to
improve breathing and quality of life. Gaps in care currently exist in the study setting
where chronic dyspnea-related diagnoses result in 32% of inpatient admissions, but
nurses do not use a validated dyspnea assessment instrument. The ATS and ACCP
recommend complete assessment of dyspnea via physical and affective domains to
improve early recognition of dyspnea exacerbation. Emerging evidence indicates that a
short patient-reported outcome questionnaire format may be the most reliable way to
measure chronic dyspnea in the clinical setting.
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“People who regard themselves as highly efficacious act, think, and feel
differently from those who perceive themselves as inefficacious. They produce
their own future, rather than simply foretell it” (Bandura, 1985).
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Appendix A – Theoretical Framework

Assess patients with mD-12
Peer Discussion Pre and Post
Patient Feedback

Inadequate Instruments
Experienced, educated
Local Practice Issues

Modified D-12
Pre-Test
Introductory Session

Diffusion
Primary Investigator Influence
Co-Worker Influence

No standard assessment
)Uncertainty
Clinical Judgment

Information Sources

Assessment
Familiar & Unfamiliar Patients
Documentation
Articulation

Validated in Multiple Diagnoses
Patient Self-Reported
Quick, Simple
Recliner Sleep Behavior

Chronic Dyspnea
Poor Recognition
Under Reporting of Symptoms
Self-Restriction Strategies
Recliner Sleep

Nurse Self-Efficacy
Earlier Recognition
Less Emergency Utilization
Fewer IP Admissions
Decreased Costs
! Certainty)
! Patient Satisfaction
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Appendix B - Dyspnea Instruments by AHRQ Classification
The literature revealed numerous, but inconsistent, means of classifying dyspnea assessment
instruments. For the purposes of this review, the instrument classification outlined for an Agency for Health
Research and Quality (AHRQ) Symposium on palliation of dyspnea was used. The AHRQ categories are:
Intensity, Situational or Functional, Effect on Health-Related Quality of Life (HRQoL), and Qualitative
Descriptors (Mularski et al., 2010).
Intensity Rating Instruments are one-dimensional scales that seek to ask the patient to assign a number or
quantity to the symptom of dyspnea at a singular moment in time. Examples are the Visual Analog Scale
(VAS), Borg/Modified Borg Scale, and the Numeric Rating Scale (NRS). These instruments may be
sufficiently sensitive for initial management. The VAS is used in clinical and research settings to measure
intensity, but has weak reliability. It is similar to the 0/10 pain scale. It is most useful for within-subjects
measures. The modified Borg Scale is a10-point scale of intensity developed to measure the rate of
perceived exertion in healthy subjects, and now commonly used in COPD. It is more reproducible than
VAS, is most sensitive in post-activity testing such as after pulmonary rehabilitation, but dyspnea ratings are
not reproducible with physiologic indicators such as oximetry. It has usefulness for phone assessment. The
NRS is also a 0-10 scale of intensity, easy for patients to use, and correlates well with the VAS. It is more
repeatable than VAS (Bausewein et al., 2006).
Situational/Functional Instruments are multidimensional measures. The Medical Research Council
Dyspnea Scale (MRC) is not sensitive enough to capture change after intervention, and not reliable in
clinical practice. It is widely used to assess prevalence in epidemiological studies. The Oxygen Cost
Diagram (OCD) is a retrospective measure of patient report of how dyspnea hinders daily activities. It
correlates well with 6-minute walking test, but not pulmonary function tests. The Baseline Dyspnea
Index/Transitional Dyspnea Index (BDI/TDI) is an interviewer-administered 5-category test of magnitude of
task, magnitude of effort, and functional impairment. It is sensitive enough to capture acute change/COPD
exacerbation and the TDI can trend changes from baseline condition.
Health Related Quality of Life (HRQoL) Instruments are complex, comprehensive, lengthy and
burdensome for patients in clinical care settings, but effective for research. There is good correlation with
dyspnea intensity and HRQoL measures. The Chronic Respiratory Disease Questionnaire (CRQ) is the most
widely used. However, it is COPD specific and not sensitive to small condition changes. The St. George
Respiratory Questionnaire (SGRQ) is an interviewer supervised, comprehensive, 76-item scale specific to
asthma, COPD, and bronchiectasis that takes15-25 minutes to complete, and is widely used in research
(Bausewein et al., 2006).
Qualitative Descriptors are verbal descriptors related to dyspnea intensity such as heavy/fast breathing and
work/effort, but are not specific enough to be useful in clinical practice (Mularski, 2010).
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Appendix C - Modified Dyspnoea-12 Assessment (mD-12) Template
1.

☐ Nurse cannot assess due to cognitive impairment or alteration in mentation.

2.

Your provider and nurses are testing a new way of asking about your breathing. These questions are
designed to help us learn more about your breathing. It will take less than 5 minutes.

3.

I will read each question, and then ask you to the best answer that matches your breathing “these days”.
Then, I will ask you to answer each as none, mild, moderate, or severe. For example, the first statement is,
“My breath does not go in all the way.” Answer none, mild, moderate, or severe. Do you have any
questions? Please answer all items as best as you are able. Thank you.

Score
None
Mild
Moderate
Severe
Total
Item
=0
=1
=2
=3
1 My breath does not go in all the way
2 My breathing requires more work
3 I feel short of breath
4 I have difficulty catching my breath
5 I cannot get enough air
6 My breathing is uncomfortable
7 My breathing is exhausting
8 My breathing makes me feel depressed
9 My breathing makes me feel miserable
10 My breathing is distressing
11 My breathing makes me agitated
12 My breathing is irritating
TOTAL
Reproduced from: Quantification of dyspnoea using descriptors: Development and initial testing of the Dyspnoea-12 by J.
Yorke, S. H. Moosavi, C. Shuldham, & P. W. Jones, Thorax, 65(1): 21-26, 2010. With permission from BMJ Publishing
Group Ltd.
4.

Next, I will ask 3 questions about where you prefer to sleep and why. We want to do a better job at finding
out about your most comfortable nighttime position.
Sleeping Posture/Preferences
#1 On most nights, where do you
sleep?

#2 On most nights, how do you sleep?

The reason you sleep THIS WAY IS?
Nurses: please document anything/all
comments the patient says here.

Drop-down menu
•
A standard bed
•
A standard bed with my head elevated on:
* Pillows
* Other:
•
A hospital bed
•
A recliner chair
* With legs elevated
* With legs down
•
Other:
•
Lying flat
•
Head elevated
•
Legs elevated
•
Other:
Drop-down menu:
* I can breathe better
* Other:
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Appendix D - Pre-test for Dyspnea Assessment Project
1. I am confident in assessing dyspnea.
☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
2. I am confident that I can assess dyspnea in patients I am familiar with.
☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
3. I am confident that I can assess dyspnea in patients that I am not familiar with.
☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
4. I am confident that I can make sound clinical decisions related to dyspnea.
☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
5. I am confident that I can accurately document dyspnea symptoms.
☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
6. I am confident that I can articulate changes in dyspnea that indicate
improvement or worsening in a patient’s status.
☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
7. What method(s) do you use for assessing for dyspnea?
8. What challenges or barriers do you encounter when assessing for dyspnea?

9. What challenges or barriers do you encounter when documenting a dyspnea
assessment?
10. What challenges do you encounter when articulating dyspnea symptoms to team
members?
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Appendix E - Post-test for Dyspnea Assessment Project
1.

I am confident in assessing dyspnea.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
2.

I am confident that I can assess dyspnea in patients I am familiar with.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
3.

I am confident that I can assess dyspnea in patients that I am not familiar with.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
4.

I am confident that I can make sound clinical decisions related to dyspnea.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
5.

I am confident that I can accurately document dyspnea symptoms.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
6.

I am confident that I can articulate changes in dyspnea that indicate improvement or
worsening in a patient’s status.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
7.

I found the Dyspnoea-12 Questionnaire easy to use.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
8.

The Dyspnoea-12 Questionnaire was helpful in assessing my patients’ symptoms.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
9.

All questions on the Dyspnoea-12 tool were clearly stated for my patients.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
10.

The template was helpful in understanding whether the patient’s sleeping preference
was related to dyspnea.

☐ Strongly agree. ☐ Agree. ☐ Neither agree nor disagree. ☐ Disagree ☐ Strongly disagree
11.

Overall, the template was easy to use.

☐ Strongly agree ☐ Agree ☐ Neither agree nor disagree ☐ Disagree ☐ Strongly disagree
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12. Please estimate how often you performed assessment with the Dyspnea-12 tool and
entered it into the CPRS template:
☐ about ¼ of the time (0-25% of my patient visits)
☐ about ½ of the time (26-50% of my patient visits)
☐ about ¾ of the time (51-75% of my patient visits)
☐ always or most of the time (76-100% of my patient visits)
13.

What was most helpful about using the template?

14.

What was least helpful about using the template?

15.

Would you use the template in the future? Why or Why not?

16.

17.

What changes, if any, have you made in your method(s) for assessing dyspnea as a
result of using this template?
Please share any comments or suggestions about the template.

18. Please share any comments or suggestions about conducting an assessment of a
symptom like dyspnea:
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Appendix F - Capstone Dissemination Timeline in Months View
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Appendix G – Capstone Data Tables
Table G1 - Template Use All Subjects
n = 10

Completed
Visits

Template
Used

% Use

A

49

20

40.8

B

1

0

0.0

C

59

52

88.1

D

46

22

47.8

E

25

2

8.0

F

11

3

27.3

G

45

30

66.7

H

43

23

53.5

I

41

37

90.2

J

48

8

16.7

Total

368

197

53.5

Percentage

Table G2 Self-Reported Template
Usage: Q12 (n = 10)
90.2
66.7
53.5
47.8
27.3
16.7
8.0

88.1

100.0

40.8

50.0

0.0

0.0
A B C D E F G H

I

J

Clinician

Table G3
Admissions for Cardiorespiratory Conditions*
Admissions for
Data Collection
C-R Conditions*
Period
CY 2014

Total
126

Count
39

%
30.1

Q4 2014

39

13

33.3

01-12-15 to 03-15-15

21

7

33.3

C *CHF, COPD (includes Bronchitis), Pneumonia, Pulmonary
Fibrosis, Respiratory Failure and Shortness of Breath

Number of Responses

Table G4
Change in "Strongly Agree": Q1 - Q6 (n = 10)
6
4

5

4
2

2

2

3

2
0

3
1

1

Post

2
0

0
1

2

3

4

Question

5

6

Pre
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Appendix H – Capstone Data Analysis Tables
Table H1 SA Response Crosstabulation
Test
Pre-Test
SA Response

Strongly Agree

Count

Not Strongly Agree

Post-Test

6

19

25

Expected Count

12.5

12.5

25.0

Count

294

281

575

287.5

287.5

575.0

300

300

600

300.0

300.0

600.0

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

.013

.006

Expected Count
Total

Total

Count
Expected Count

Table H2 chi-Square Test-of-Independence
Value

df

Asymp.
Sig. (2sided)

a

1

.008

Continuity
Correction

6.010

1

.014

Likelihood Ratio

7.397

1

.007

Pearson Chi-Square

7.054

Fisher's Exact
Test
Linear-by-Linear
Association
N of Valid Cases

7.042

1

.008

600

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.50.
b. Computed only for a 2x2 table

Table H3 Tests of Norm ality
Test

Kolmogorov-Smirnov
Statistic

Strongly Agree = 5

a

df

Shapiro-Wilk
Sig.

Statistic

Pre-Test

.202

6

.200

*

Post-Test

.223

6

.200

*

df

Sig.

.853

6

.167

.908

6

.421

*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction

Table H4 Group Statistics
Test

N

Computed

Mean

Pre-Test

6

5.00

Std.
Deviation
4.472

Post-Test

6

15.83

5.845

Std. Error
Mean
1.826
2.386

Table H5 Group Statistics
Test
Strongly Agree = 5

N

Mean

Pre-Test

6

1.00

Std.
Deviation
.894

Post-Test

6

3.17

1.169

Std. Error
Mean
.365
.477
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Table H6 Correlations
Descriptive Statistics
Mean
Post-Strongly Agree
=5
Pre-Strongly Agree
=5

Std. Deviation

N

3.17

1.169

6

1.00

.894

6

Table H7 Correlations
Post-Strongly
Agree = 5
Post-Strongly
Agree = 5

Pearson Correlation

1

.765

Sig. (2-tailed)

.076

N
Pre-Strongly
Agree = 5

Pre-Strongly Agree = 5

6

6

Pearson Correlation

.765

1

Sig. (2-tailed)

.076

N

6

6

Table H8 Nonparametric Correlations

Kendall's tau_b

Post-Strongly Agree
=5

Correlation
Coefficient
Sig. (2-tailed)

PostStrongly
Agree = 5
1.000

.101

N
Pre-Strongly Agree
=5

Correlation
Coefficient
Sig. (2-tailed)

Post-Strongly Agree
=5

Correlation
Coefficient
Sig. (2-tailed)

6

.641

1.000

6

6

1.000

.739
.094

N
Pre-Strongly Agree
=5

6

.101

N
Spearman's rho

PreStrongly
Agree = 5
.641

Correlation
Coefficient
Sig. (2-tailed)

6

6

.739

1.000

.094

N

6

6

Table H9 Sym m etric M easures
Value
Nominal by
Nominal
N of Valid Cases

Phi
Cramer's V

-.108

Approx.
Sig.
.008

.108

.008

600
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Table H10 Mann-Whitney Test
Test Statistics

a

Strongly Agree = 5
Mann-Whitney U

2.000

Wilcoxon W

23.000

Z

-2.622

Asymp. Sig. (2tailed)
Exact Sig. [2*(1tailed Sig.)]
a. Grouping Variable: Test

.009
.009

b

b. Not corrected for ties.

Table H11 Independent Samples Test
Levene's Test for Equality of
Variances
F
Sig.

Computed

Equal variances
assumed
Equal variances not
assumed

.432

.526

t-test for Equality of Means
t

df

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

95% Confidence
Interval of the
Difference
Lower
Upper

-3.606

10

.005

-10.833

3.005

-17.528

-4.139

-3.606

9.360

.005

-10.833

3.005

-17.591

-4.076

Table H12 Independent Samples Test
Levene's Test for Equality of
Variances
F
Sig.

Strongly Agree = 5

Equal variances
assumed
Equal variances not
assumed

.432

.526

t-test for Equality of Means
t

df

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

95% Confidence
Interval of the
Difference
Lower
Upper

-3.606

10

.005

-2.167

.601

-3.506

-.828

-3.606

9.360

.005

-2.167

.601

-3.518

-.815
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Appendix I - Pre-Test Qualitative Data
QUALITATIVE
Q7

Q8

Q9

Method(s) for assessing dyspnea

Challenges or barriers assessing
dyspnea

Observation, auscultation (with
scope and "naked ears"),
interview/verbal report by patient

Patient's perception of dyspnea;
patient's verbalization of their
normal.

Visual assessment, lung
assessment. Questioning SOB with
activity or just sitting. Ask if they
sleep elevated. Use of inhalers

Patients will deny SOB but then
admit that they can't breathe lying
down.

Need to ask more questions than "Do
you have any SOB?"

Can't think of any.

Auscultation of lung sounds,
respiratory rate, O2 sats, SOB
w/activity. Above w/ambulation

Sometimes difficulty w/positioning
in home or cooperation of patient
(dementia).

Sometimes unsure of specific
terminology: i.e. different types of lung
sounds

Same as #9

VS; oxygen monitor; history and
current conditions

Redo sats

History of smoking; vocabulary related
to lung sounds

Common vocabulary

Patient has difficulty describingfrequently respond with
"sometimes" or "kind-of"

No clear descriptors or guidelines. How
do I know when an intervention is
appropriate? There is no clear way to
assess time frame - is this new? How
long?

It is unclear when to note changes. Is
this information communicated only
when the patient requires an
intervention? When is this felt to be
pertinent? When there is a change
from patient's baseline?

Assess respiratory rate, work of
breathing, or verbal response from
patient.

Challenges or barriers documenting
dyspnea

Q10

?

Challenges or barriers articulating
dyspnea
Team members on a "different page"-We're not using a standardized tool.
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Patients' report of dyspnea at rest
or w/activity; respiratory rate,
oxygen saturation, use of accessory
muscles, ability to converse

May not be familiar with patient's
baseline. Patients do not always
recognize changes in dyspnea or are
reluctant to report changes.

Consistency with providers and
standards and quality of documentation.
No consistent parameters.

Knowing that the definition of terms
used means the same thing.

Color, nails, activity tolerance,
talking, listening, looking, weight,
when do they feel relief--meds,
positional, stressors

Patient denial; What's normal for
patient.

Unsure at this time. I chart what I have
assessed.

I know, but do have problems
articulating…finding the right words
sometimes.

I ask patient about specific
activities and positional changes. I
ask what makes it worse, or better.

I think some patients aren't always
forthcoming and/or become
comfortable with their baseline.
Sometimes the patient has cognitive
difficulties such as memory issues.

Sometimes documentation can be too
lengthy and time consuming.

I can't think of any at the present
moment.

Resp rate, O2 sat, LPM oxygen
up/down or same rate, WOB,
patient self-report, CG report, sleep
in chair due to SOB or not

Some patients are not excellent
historians or reporters of dyspnea;
dementia

Many patients' dementia prevents
accurate understanding and
documentation

Giving objective findings ok, but
giving & reporting subjective findings
is difficult.

Increased respirations, labored
breathing, chest retractions,
exhaustion

Time during visit. Treatment
management

Documentation sometimes doesn't
match person's level of dyspnea.

Level of severity of dyspnea
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Appendix J - Post-Test Qualitative Data
QUALITATIVE
Q13
Most helpful
ab/using the
template

Q14

Q15

Q18
Comments or
suggestions about
conducting an
assessment of a
symptom like
dyspnea

Comments or
suggestions about the
template

#1 is least helpful

I think I can assess the patient
for dyspnea w/o the template.
It's too detailed and the
patient I assessed didn't want
to answer with a number,
rather he wanted to answer in
the narrative.

None

Too much
documentation. Need
specifics about total
scores and interventions
for those score ranges.

Shorten the
assessment and
documentation.
(I only had an
opportunity for ONE
patient.)

Drop-down to
highlight 0-3
would've been
quicker/easier

No-difficult for patient to
answer w/o stories or
qualifications of answers

Better idea of
what/how to ask
dyspnea questions

Patients had difficulty
rating 0-3. Always
wanted to qualify
answers, i.e. with or w/o
exercise or pain

No response

Yes, but would modify and
make a few changes.

I address dyspnea
more openly and ask
for further
clarification.

Overall, I thought it was
helpful, and hopefully
identified patients who
have been saying "no" to
SOB in the past.

Important for nurses to
ask the patient more
questions than just
"Are you SOB-yes or
no." Emphasized the
importance of sleeping
in bed, pillows, and
effect on overall
breathing. Therefore,
important questions
for nurses to ask.

No, I did not learn anything
new that I didn't already know
about my patients.

If they sleep in a
regular bed and
elevated whether it
is for breathing or
just for comfort muscle vs. GERD

I disliked the none-mildmoderate-severe. Felt it
should have been
worded never-rarelysometimes-frequently

See # 17.

Use in the future? Why or
why not?

#2 is helpful

Easy, quick
access via CPRS

The questions
about why they
sleep elevated or
not

Q17

What changes have
you made in
assessing dyspnea
after using the
template

Least helpful
ab/using the
template

Allowed/encoura
ged discussion
with patient that
may not have
happened before.

Q16

Some patients had
difficulty
understanding the
questions.

The grading of the
answers
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Getting
patients/vets to
think more
"critically" about
their breathing.

The statement "these
days" does this mean
in the last 2-3 days?
Last week? Last
month? Since I
assessed you last? It
wasn't clear to me if
the statements
pertained to the
veteran "at rest" vs.
"w/activity".
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Portions - Like statement #2,
5, 6, 7, 8

More specific
questions /
statements

"Tell the patient we are
testing a new way of
asking "our veterans"
about their breathing. I'm
going to read a statement
and ask you to respond if
that is true for you - if it
is true - then is it mildly,
moderately, or
completely/severely true.
Have 2 columns to
score--one for at rest,
one for w/exertion.

Check more
frequently to see if
sleeping has
changed. Some
patients had
changed from bed to
recliner or increased
HOB and I was not
aware.

Easy to use. Maybe
make it clearer for the
patients.

It was interesting and
helpful.

Able to get more
detail.

No response

No response

No response

No response

No response

No response

No response

No response

Very easy to use

Nothing

Yes: I learned more about
dyspnea in my patients. I
didn't know how short of
breath some of them really
are.

The first few
questions

Too confusing
questions for patients

Yes, but only with patients
who actually have dyspnea.

Full assessment
on pulmonary

Nothing

Yes

The template

No response

Yes: helpful pulling answers
from the vets

It is helpful with
a patient you are
not familiar with
to get a better
understanding of
their dyspnea.

Patients had
difficulty
differentiating
between the
descriptors. They felt
like they were asking
the same thing.

Yes, I think it is helpful for
the initial assessment and in
recognizing a change in
dyspnea.

Ask same questions
but in an easier way
to start. I always
struggled with the
starting part because
it felt backward.
Any increase in
dyspnea
It provided me with
several different
descriptors that
patients may
identify with better
in terms of their
dyspnea.

The vets with
respiratory difficulties
seem to appreciate the
concern shown w/a
questionnaire such as
this. The vets (some)
who don't have
respiratory difficulties
were
frustrated/aggravated
w/the questionnaire.
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When you submit your order you are subject to the terms and conditions set out below. You will also have agreed to the Copyright Clearance Center's ("CCC") terms and conditions
regarding billing and payment https://s100.copyright.com/App/PaymentTermsAndConditions.jsp. CCC is acting as the BMJ Publishing Group Limited's ("BMJ Group's") agent.
Subject to the terms set out herein, the BMJ Group hereby grants to you (the Licensee) a non-exclusive, on-transferable licence to re-use material as detailed in your request for this/those
purpose(s) only and in accordance with the following conditions:
1) Scope of Licence: Use of the Licensed Material(s) is restricted to the ways specified by you during the order process and any additional use(s) outside of those specified in that
request, require a further grant of permission.
2) Acknowledgement: In all cases, due acknowledgement to the original publication with permission from the BMJ Group should be stated adjacent to the reproduced Licensed
Material. The format of such acknowledgement should read as follows:
"Reproduced from [publication title, author(s), volume number, page numbers, copyright notice year] with permission from BMJ Publishing Group Ltd."
3) Third Party Material: BMJ Group acknowledges to the best of its knowledge, it has the rights to licence your reuse of the Licensed Material, subject always to the caveat that
images/diagrams, tables and other illustrative material included within, which have a separate copyright notice, are presumed as excluded from the licence. Therefore, you should ensure
that the Licensed Material you are requesting is original to BMJ Group and does not carry the copyright of another entity (as credited in the published version). If the credit line on any
part of the material you have requested in any way indicates that it was reprinted or adapted by BMJ Group with permission from another source, then you should seek permission from
that source directly to re-use the Licensed Material, as this is outside of the licence granted herein.
4) Altering/Modifying Material: The text of any material for which a licence is granted may not be altered in any way without the prior express permission of the BMJ Group. Subject
to Clause 3 above however, single figure adaptations do not require BMJ Group's approval; however, the adaptation should be credited as follows:
"Adapted by permission from BMJ Publishing Group Limited. [Publication title, author, volume number, page numbers, copyright notice year]
5) Reservation of Rights: The BMJ Group reserves all rights not specifically granted in the combination of (i) the licence details provided by you and accepted in the course of this
licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment Terms and Conditions.
6) Timing of Use: First use of the Licensed Material must take place within 12 months of the grant of permission.
7). Creation of Contract and Termination: Once you have submitted an order via Rightslink and this is received by CCC, and subject to you completing accurate details of your
proposed use, this is when a binding contract is in effect and our acceptance occurs. As you are ordering rights from a periodical, to the fullest extent permitted by law, you will have no
right to cancel the contract from this point other than for BMJ Group's material breach or fraudulent misrepresentation or as otherwise permitted under a statutory right. Payment must be
made in accordance with CCC's Billing and Payment Terms and conditions. In the event that you breach any material condition of these terms and condition or any of CCC's Billing and
Payment Terms and Conditions, the license is automatically terminated upon written notice from the BMJ Group or CCC or as otherwise provided for in CCC's Billing and Payment
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Terms and Conditions, where these apply. Continued use of materials whereas licence has been terminated, as well as any use of the Licensed Materials beyond the scope of an
unrevoked licence, may constitute intellectual property rights infringement and BMJ Group reserves the right to take any and all action to protect its intellectual property rights in the
Licensed Materials.
8. Warranties: BMJ Group makes no express or implied representations or warranties with respect tithe Licensed Material and to the fullest extent permitted by law this is provided on
an "as is" basis. For the avoidance of doubt BMJ Group does not warrant that the Licensed Material is accurate or fit for any particular purpose.
9. Limitation of Liability: To the fullest extent permitted by law, the BMJ Group disclaims all liability for any indirect, consequential or incidental damages (including without
limitation, damages for loss of profits, information or interruption) arising out of the use or inability to use the Licensed Material or the inability to obtain additional rights to use the
Licensed Material. To the fullest extent permitted by law, the maximum aggregate liability of the BMJ Group for any claims, costs, proceedings and demands for direct losses caused by
BMJ Group's breaches of its obligations herein shall be limited to twice the amount paid by you to CCC for the licence granted herein.
10. Indemnity: You hereby indemnify and hold harmless the BMJ Group and their respective officers, directors, employees and agents, from and against any and all claims, costs,
proceeding or demands arising out of your unauthorised use of the Licensed Material.
11. No Transfer of License: This licence is personal to you, and may not be assigned or transferred by you without prior written consent from the BMJ Group or its authorised agent(s).
BMJ Group may assign or transfer any of its rights and obligations under this Agreement, upon written notice to you.
12. No Amendment Except in Writing: This licence may not be amended except in a writing signed by both parties (or, in the case of BMJ Group, by CCC on the BMJ Group's
behalf).
13. Objection to Contrary terms: BMJ Group hereby objects to any terms contained in any purchase order, acknowledgment, check endorsement or other writing prepared by you,
which terms are inconsistent with these terms and conditions or CCC's Billing and Payment Terms and Conditions. These terms and conditions, together with CCC's Billing and
Payment Terms and Conditions (which to the extent they are consistent are incorporated herein), comprise the entire agreement between you and BMJ Group (and CCC) and the
Licensee concerning this licensing transaction. In the event of any conflict between your obligations established by these terms and conditions and those established by CCC's Billing and
Payment Terms and Conditions, these terms and conditions shall control.
14. Revocation: BMJGroup or CCC may, within 30 days of issuance of this licence, deny the permissions described in this licence at their sole discretion, for any reason or no reason,
with a full refund payable to you should you have not been able to exercise your rights in full. Notice of such denial will be made using the contact information provided by you. Failure
to receive such notice from BMJGroup or CCC will not, to the fullest extent permitted by law alter or invalidate the denial. For the fullest extent permitted by law in no event will BMJ
Group or CCC be responsible or liable for any costs, expenses or damage incurred by you as a result of a denial of your permission request, other than a refund of the amount(s) paid by
you to BMJ Group and/or CCC for denied permissions.
15. Restrictions to the license:
15.1 Promotion: BMJ Group will not give permission to reproduce in full or in part any Licensed Material for use in the promotion of the following:
a) Non-medical products that are harmful or potentially harmful to health: alcohol, baby milks and/or, sunbeds
b) Medical products that donor have a product license granted by the Medicines and Healthcare products Regulatory Agency (MHRA) or its international equivalents. Marketing of the
product may start only after data sheets have been released to members of the medical profession and must conform to the marketing authorization contained in the product license.
16.
Translation: This permission is granted for non-exclusive world English language rights only unless explicitly stated in your licence. If translation rights are granted, a
professional translator should be employed and the content should be reproduced word for word preserving the integrity of the content.
17.
General: Neither party shall be liable for failure, default or delay in performing its obligations under this Licence, caused by a Force Majeure event which shall include any act
of God, war, or threatened war, act or threatened act of terrorism, riot, strike, lockout, individual action, fire, flood, drought, tempest or other event beyond the reasonable control of
either party.
17.1
In the event that any provision of this Agreement is held to be invalid, the remainder of the provisions shall continue in full force and effect.
17.2
There shall be no right whatsoever for any third party to enforce the terms and conditions of this Agreement. The Parties hereby expressly wish to exclude the operation of the
Contracts (Rights of Third Parties) Act 1999 and any other legislation, which has this effect and is binding on this agreement.
17.3
To the fullest extent permitted by law, this Licence will be governed by the laws of England and shall be governed and construed in accordance with the laws of England. Any
action arising out of or relating to this agreement shall be brought in courts situated in England save where it is necessary for BMJ Group for enforcement to bring proceedings to bring
an action in an alternative jurisdiction.
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or +1-978-646-2777.
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable license for your reference. No payment is required.

